We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Group A streptococcal infections: reports on seasonal activity in England, 2025 to 2026
Reports of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital settings in England during the 2026 to 2027 season.
Statistical release in response to cases of Salmonella in England connected to the outbreak likely associated with imported eggs.
Monthly data and commentary on coverage achieved by the UK childhood vaccination programme in England in 2026.
Surveillance data relating to gastrointestinal pathogens.
Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.
Laboratory-confirmed cases and notifications of rubella in England.
UK quarterly data and commentary on coverage achieved by the UK childhood immunisation programme.
Laboratory-confirmed cases and notifications of mumps in England.
Outlines the quality and methodology information (QMI) relevant to the healthcare-associated infections (HCAI) accredited official statistics releases.
Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Trends in E. coli, Klebsiella spp., P. aeruginosa, MRSA and MSSA bacteraemia and C. difficile infections by financial year, from 2022 to 2025.
Trends in E. coli, Klebsiella spp., P. aeruginosa, MRSA and MSSA bacteraemia and C. difficile infections up to and including financial year 2025 to 2026 (1 April 2025 to 31 March 2026).
Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses (see important note in Details section, below).
A rapid review of evidence on the potential adverse health outcomes from long-term exposure to per- and polyfluoroalkyl substances (PFAS) or ‘forever chemicals’.
Data on the latest findings relating to antimicrobial resistance in Mycoplasma genitalium from specimens collected in sexual health clinics across England.
Number of laboratory-confirmed cases of measles by age group, region and upper tier local authority from 1 January 2026 onwards.
Annual report on the surveillance of mortality during cold episodes.
The latest quarterly reports of provisional data for syphilis and gonorrhoea diagnoses in England.
This report builds on 3 decades of UKHSA research into the radiological impact of transporting radioactive materials, focusing on the medical sector.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).